Navigation Links
WuXi PharmaTech Announces Third-Quarter 2011 Results
Date:11/10/2011

SHANGHAI, Nov. 10, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the third quarter of 2011.

Highlights

  • Third-Quarter 2011 Net Revenues Increased 24.0% Year Over Year to $104.0 Million
  • Manufacturing Services Net Revenues Grew 183.8% Year Over Year to $20.1 Million
  • Laboratory Services Net Revenues Grew 9.2% Year Over Year to $83.9 Million
  • China-Based Laboratory Services Net Revenues Increased 10.7% Year Over Year to $63.2 Million
  • GAAP Operating Income Increased 15.8% Year Over Year to $22.2 Million
  • Non-GAAP Operating Income Increased 10.1% Year Over Year to $24.9 Million
  • GAAP Diluted Earnings Per ADS Declined 53.8% Year Over Year to 27 Cents Due to Inclusion in the Prior-Year Results of a Termination Fee Relating to the Proposed Transaction with Charles River Laboratories and an Increase in the Effective Tax Rate
  • Non-GAAP Diluted Earnings Per ADS Increased 2.6% Year Over Year to 31 Cents Due to an Increase in the Effective Tax Rate
  • WuXi Refines Its Full-Year 2011 Guidance
  • Board Member Jeff Leng Elected to Audit Committee

  • Management Comment"WuXi achieved another solid quarter, driven by particularly strong revenue performances in Manufacturing Services, integrated medicinal chemistry, DMPK/ADME, toxicology, formulation, and analytical and bioanalytical services," said Dr. Ge Li, Chairman and Chief Executive Officer. "We exceeded our revenue guidance and met our operating-margin guidance for the quarter. We are on track to achieve full-year 2011 revenues of $402 to $406 million, GAAP operating margin of about 21%, and non-GAAP o
    '/>"/>

    SOURCE WuXi PharmaTech (Cayman) Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related biology technology :

    1. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
    2. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
    3. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
    4. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
    5. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
    6. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
    7. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
    8. WuXi PharmaTech Announces Third Quarter 2008 Results
    9. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
    10. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
    11. Pharmatech 2.0: Introducing Pharmatech Oncology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... 31, 2014 According to a ... Dots Market - Global Industry Analysis, Size, Share, Growth, ... valued at USD 88.5 million in 2011, which is ... at a CAGR of 53.8% from 2013 to 2023. ... at  http://www.transparencymarketresearch.com/quantum-dots.html Increasing demand for energy ...
    (Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
    (Date:7/31/2014)... Calif. (PRWEB) July 31, 2014 Held ... diagnosed patients with an overview of the disease and ... of drug side effects, as well as updates on ... grateful to Dr. Sandy Srinivas for organizing this educational ... of kidney cancer. “Sandy and her colleagues have put ...
    (Date:7/31/2014)... BOTHELL, Wash. , July 31, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... Company,s second quarter 2014 financial results will be released ... will host a conference call and live webcast at ...
    Breaking Biology Technology:Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2
    ... a new chief information officer and vice provost for ... has been narrowed to three Midwestern finalists, according to ... Kraemer, deputy CIO and associate director of the UW-Madison ... for information services and CIO at UW-Green Bay ...
    ... the United States Supreme Court has issued several rulings ... In Microsoft Corp. v. AT&T , the Supreme ... clear that United States patent law governs domestically but does not ... case , the Supreme Court addressed Section 271(f) of the ...
    ... contrarian move, the family-focused Web hosting and social networking site ... advertising and move to a subscription-only business model. The move ... announcement. , ,We find that families do not want ... Wayne Naphtal. , ,Interestingly, Web businesses have yet to find ...
    Cached Biology Technology:Supreme Court limits foreign reach of U.S. patents 2Supreme Court limits foreign reach of U.S. patents 3Supreme Court limits foreign reach of U.S. patents 4Delivering value instead of advertising - what a concept! 2Delivering value instead of advertising - what a concept! 3
    (Date:7/31/2014)... or fat cells, are inherently different. Each of these ... own role in metabolism. In the human body, white ... primary function is energy storage. On the other hand, ... are only found in a few places in the ... type of brown adipocytes, appear mixed with brown adipocytes ...
    (Date:7/31/2014)... NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication company ... and consumers wanting to learn more about its  ... on-air today, July 31 st . ... featured in a segment of NewsWatch, a weekly ... the History Channel, FYI Network today. ...
    (Date:7/31/2014)... Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios ... British Medical Journal Open (BMJ Open) (i) ... Open article looked at the effects of tree ... tree nut consumption resulted in a significant decrease in ... article focused on the effect of tree nuts ...
    Breaking Biology News(10 mins):Hope for the overweight 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3New international tree nut council study looks at nuts, diabetes and metabolic syndrome 2
    ... BioMed Central Research Awards were announced yesterday at an ... event was attended by shortlisted authors, eminent researchers from ... The Research Awards, now in their second year, ... accessible by open access publication. The Awards celebrate the ...
    ... by two Texas A&M University anthropologists now believes the ... years earlier than the 13,500 years ago previously thought, ... findings are outlined in a review article in Science ... in the Americas, which synthesizes new data suggesting the ...
    ... most complete plesiosaur fossils recovered in North America, and ... a new genus of the prehistoric aquatic predator according ... the creature after its remains were uncovered in a ... In a paper published in the current issue ...
    Cached Biology News:Excellence in open access research celebrated at BioMed Central awards dinner 2Ancient reptile rises from Alberta oil sands 2Ancient reptile rises from Alberta oil sands 3
    ... Human Cytokeratin TYPE II Reacts with ... Including epidermal cell keratin of 86 and ... 67kD. Broad keratin reactivity is found on ... Immunogen: Human epidermal cells ...
    ... System is intended for use in the ... an in-house validated method for in vitro ... of interest. • ... hybridization capture assay designed to detect amplified ...
    ... these culture chambers produce cell yields in ... range and are useful alternatives to multiple ... mechanical • strength and structural integrity • ... Certified nonpyrogenic and sterilized by gamma irradiation, ...
    Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
    Biology Products: